Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 4/1997

01-03-1997

Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs

Authors: P. Poulsen, A. A. Vaag, K. O. Kyvik, D. Møller Jensen, H. Beck-Nielsen

Published in: Diabetologia | Issue 4/1997

Login to get access
Metadata
Title
Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs
Authors
P. Poulsen
A. A. Vaag
K. O. Kyvik
D. Møller Jensen
H. Beck-Nielsen
Publication date
01-03-1997
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/1997
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s001250050698

Other articles of this Issue 4/1997

Diabetologia 4/1997 Go to the issue

Originals

Rapid development of glomerulosclerosis in diabetic Dahl salt-sensitive rats

OriginalPaper

Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients

OriginalPaper

Proliferation and differentiation in the human fetal endocrine pancreas

OriginalPaper

Mechanisms of arginine-induced increase in cytosolic calcium concentration in the beta-cell line NIT-1

OriginalPaper

Endogenous glucose production, gluconeogenesis and liver glycogen concentration in obese non-diabetic patients

OriginalPaper

Beta-cell hypersensitivity to glucose following 24-h exposure of rat islets to fatty acids
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits